SCHEMBL6492606

SCHEMBL6492606

CON(C)C(=O)c1cccc(C(=O)c2ccccc2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
PTGS1 P23219 3/20 0.48
PTGS2 P35354 3/20 0.48
HPGD P15428 4/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
PBRM1 Q86U86 1/20 0.47
ALDH1A1 P00352 3/20 0.47
CTSL P07711 1/20 0.47
CTSK P43235 1/20 0.47
HPGDS O60760 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
MAPT P10636 2/20 0.45
CXCR1 P25024 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15281239 0.89 KMT2A (0.50) ATMTDP1L3MBTL1MEN1KMT2A
SCHEMBL3303829 0.88 HPGD (0.56) ATMTDP1L3MBTL1MEN1KMT2A
SCHEMBL6481629 0.86 ATM (0.46) ATMTDP1L3MBTL1MEN1KMT2A
SCHEMBL16214051 0.84 MEN1 (0.46) TDP1MEN1KMT2AHPGDALDH1A1
SCHEMBL28777 0.84 MLYCD (0.54) MEN1KMT2AHPGDNPC1RAB9A
SCHEMBL772236 0.83 KMO (0.53) TDP1MEN1KMT2AHPGDMAPT
Hydrochloric Acid SCHEMBL7476159 0.82 MLYCD (0.53) KMT2AHPGDNPC1RAB9AALDH1A1
SCHEMBL2424190 0.81 TSHR (0.50) MEN1KMT2ANPC1RAB9AALDH1A1
SCHEMBL8271457 0.81 PARP1 (0.54) TDP1L3MBTL1MEN1KMT2ACYP2C19
SCHEMBL6479644 0.81 HPGD (0.43) ATMTDP1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050010048-A1 Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors ZHUANG LINGHANG (US) 2005-01-13 US disclosed
EP-1333831-A2 AZA-AND POLYAZA-NAPHTHALENYL KETONES USEFUL AS HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2003-08-13 EP disclosed
WO-2002036734-A2 AZA-AND POLYAZA-NAPHTHALENYL KETONES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2002-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050010048-A1 Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors POLI, CYP51A1, DUT ATM 3604/4885TDP1 1008/4885L3MBTL1 1960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.